Case Study: Treating KRAS-Mutant Adenocarcinoma

preview_player
Показать описание
Panelists discuss the second-line treatment of a 46 year-old woman with KRAS-positive nonsquamous non-small cell lung cancer following treatment with bevacizumab.

  1. OncLive
  2. cancer
  3. oncology
  4. KRAS
  5. Adenocarcinoma (Disease Or Medical Condition)
  6. Lung Cancer (Disease Or Medical Condition)
Рекомендации по теме
Case Study: Treating 0:04:59

Case Study: Treating KRAS-Mutant Adenocarcinoma

Case Study: Second-Line 0:09:14

Case Study: Second-Line Treatment of Adenocarcinoma

Treatment for KRAS 0:07:44

Treatment for KRAS G12C Mutated NSCLC with High Tumor Mutational Burden -Case-Based Panel Discussion

Case Study: Mutation-Negative 0:08:36

Case Study: Mutation-Negative Patient With Lung Adenocarcinoma

The case for 0:01:07

The case for separating G12D mutations in studying KRAS-mutant PDAC

Innovations within Precision 0:08:47

Innovations within Precision Oncology: Evolution of a biomarker—a case study of KRAS G12C

Case 2: Frontline 0:04:15

Case 2: Frontline Treatment Data in Stage IV NSCLC

Treatment Options for 0:05:33

Treatment Options for KRAS-Mutant Unresectable mCRC

Case 2: Stage 0:02:49

Case 2: Stage IV PD-L1–Negative, KRAS-Mutant Lung Adenocarcinoma

Targeting non-G12C KRAS 0:01:10

Targeting non-G12C KRAS mutations in NSCLC

Strategies for Overcoming 0:21:37

Strategies for Overcoming KRAS Mutations

Laboratory Medicine and 0:41:26

Laboratory Medicine and Pathology in Individualized Medicine: A Guide to Cancer Treatment

Targeted Therapy for 0:07:23

Targeted Therapy for KRAS-Mutant NSCLC

CodeBreak 100: assessing 0:01:17

CodeBreak 100: assessing sotorasib in patients with KRAS p.G12C-mutant pancreatic cancer

Testing for KRAS 0:06:30

Testing for KRAS Mutations in NSCLC

Advances in the 0:02:12

Advances in the management of KRAS-mutant NSCLC

Lung Cancer Treatments 0:03:46

Lung Cancer Treatments for KRAS Mutation

Case Study: Maintenance 0:04:26

Case Study: Maintenance Therapy in Squamous Non-Small Cell Lung Cancer

KRAS Mutations in 0:06:52

KRAS Mutations in Solid Tumors

Targeting HER2, BRAF, 0:21:10

Targeting HER2, BRAF, KRAS, MET

Dr. Cercek on 0:00:57

Dr. Cercek on the Need for Treatment Options in KRAS Mutated mCRC

Therapeutic Algorithm for 0:26:13

Therapeutic Algorithm for NSCLC Adenocarcinoma

Challenges of KRAS-targeting 0:01:25

Challenges of KRAS-targeting for lung cancer therapy

Case 3: KRAS-Mutated 0:07:57

Case 3: KRAS-Mutated Metastatic Colon Cancer

join shbcf.ru